Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)
CompletedOBSERVATIONAL
Enrollment
67
Participants
Timeline
Start Date
January 8, 2022
Primary Completion Date
February 2, 2024
Study Completion Date
August 2, 2024
Conditions
Allergic Bronchopulmonary Aspergillosis (ABPA)
Trial Locations (1)
76031
University Rouen Hospital, Rouen
All Listed Sponsors
lead
University Hospital, Rouen
OTHER
NCT07055230 - Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA) | Biotech Hunter | Biotech Hunter